Advancement of Targeted Ultrasound Contrast Agents and their Applications in Molecular Imaging and Targeted TherapyFENG YANG; CHEN, Zhi-Yi; YAN LIN et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 8, pp 1516-1527, issn 1381-6128, 12 p.Article

Binding Site Detection and Druggability Prediction of Protein Targets for Structure-Based Drug Design : Rational Drug Design with the Aid of Molecular Modeling and BioinformaticsYAXIA YUAN; JIANFENG PEI; LUHUA LAI et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 12, pp 2326-2333, issn 1381-6128, 8 p.Article

Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy : Novel Targets and Biomarkers for Anti-atherosclerotic TherapySOBENIN, Igor A; CHISTIAKOV, Dimitry A; BOBRYSHEV, Yuri V et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 33, pp 5954-5962, issn 1381-6128, 9 p.Article

Cardioprotection Techniques: Preconditioning, Postconditioning and Remote Con-ditioning (Basic Science) : No Reflow: What's in a Name?HAUSENLOY, Derek J.Current pharmaceutical design (Print). 2013, Vol 19, Num 25, pp 4544-4563, issn 1381-6128, 20 p.Article

Cardiovascular Molecular Imaging: New Methodological Strategies : Modifying Cardiovascular Risk Factors: New Markers of Cardiovascular DamageFILOMENA SANTARELLI, Maria; POSITANO, Vincenzo; MENICHETTI, Luca et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 13, pp 2439-2446, issn 1381-6128, 8 p.Article

Cdc20: A Potential Novel Therapeutic Target for Cancer Treatment : Targeting the Ubiquitin-Proteasome Pathway - Current Perspectives and Future DirectionsZHIWEI WANG; LIXIN WAN; JIATENG ZHONG et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 18, pp 3210-3214, issn 1381-6128, 5 p.Article

Cutaneous Complications of Anderson-Fabry Disease : Anderson Fabry Disease: A Multiorgan Metabolic Disease Susceptible of TreatmentPISTONE, Giuseppe; RIZZO, Daniele; BONGIORNO, Maria Rita et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 33, pp 6031-6036, issn 1381-6128, 6 p.Article

Emerging Role of the Ubiquitin-proteasome System as Drug Targets : Targeting the Ubiquitin-Proteasome Pathway - Current Perspectives and Future DirectionsKAR, Gozde; KESKIN, Ozlem; FRATERNALI, Franca et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 18, pp 3175-3189, issn 1381-6128, 15 p.Article

Enterobacteriaceae that Produce Extended-spectrum β-lactamases and AmpC β-lactamases in the Community: The Tip of the Iceberg? : Resistance in Gram-negative Pathogens: A Threat to global HealthPITOUT, Johann D. D.Current pharmaceutical design (Print). 2013, Vol 19, Num 2, pp 257-263, issn 1381-6128, 7 p.Article

FDA-approved Drugs Selected Using Virtual Screening Bind Specifically to G-quadruplex DNA : Molecular Modeling and QSAR Studies for Drug DesignCASTILLO-GONZALEZ, Daimel; PEREZ-MACHADO, Gisselle; GUEDIN, Aurore et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 12, pp 2164-2173, issn 1381-6128, 10 p.Article

Fabry Disease and Cardiovascular Involvement : Anderson Fabry Disease: A Multiorgan Metabolic Disease Susceptible of TreatmentANASTASAKIS, Aris; PAPATHEODOROU, Efstathios; STERIOTIS, Alexandros Klavdios et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 33, pp 5997-6008, issn 1381-6128, 12 p.Article

Fibroblast Growth Factor-2, Bone Homeostasis and Fracture Repair : Bone Morphogenetics Proteins for Bone Regeneration and Their AlternativesYURONG FEI; GRONOWICZ, Gloria; HURLEY, Marja M et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 19, pp 3354-3363, issn 1381-6128, 10 p.Article

Fluorescent SNAP-Tag Galectin Fusion Proteins as Novel Tools in Glycobiology : The SNAP-tag Technology - A Versatile Tool with many ApplicationsKUPPER, Christiane E; BÖCKER, Sophia; ELLING, Lothar et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 30, pp 5457-5467, issn 1381-6128, 11 p.Article

Glucocorticoid Excess Induces Accumulation of Cardiac Glycogen and Triglyceride: Suggested Role for AMPK : Metabolic Syndrome and Cardiovascular Health: A Look Beyond the HorizonPUTHANVEETIL, Prasanth; RODRIGUES, Brian.Current pharmaceutical design (Print). 2013, Vol 19, Num 27, pp 4818-4830, issn 1381-6128, 13 p.Article

Growth Differentiation Factor 5 Regulation in Bone Regeneration : Bone Morphogenetics Proteins for Bone Regeneration and Their AlternativesLI JIN; XUDONG LI.Current pharmaceutical design (Print). 2013, Vol 19, Num 19, pp 3364-3373, issn 1381-6128, 10 p.Article

HPV Pathway Profiling: HPV Related Cervical Dysplasia and Carcinoma Studies : Explorating Molecular and Clinical Management of Patients int he Follow up of the HPV Related Uterine LesionsSCHOLL, Susy M; KAMAL, Maud; DE KONING, Léanne et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 8, pp 1379-1394, issn 1381-6128, 16 p.Article

Histone Acetylation: From Code to Web and Router Via Intrinsically Disordered Regions : Targeting Histone Acetylation for NeuroprotectionHORIKOSHI, Masami.Current pharmaceutical design (Print). 2013, Vol 19, Num 28, pp 5019-5042, issn 1381-6128, 24 p.Article

Hsp90 Inhibitors as Anti-Cancer Agents, from Basic Discoveries to Clinical Development : Molecular Chaperones as Drug TargetsSOGA, Shiro; AKINAGA, Shiro; SHIOTSU, Yukimasa et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 3, pp 366-376, issn 1381-6128, 11 p.Article

Inorganic Phosphate as a Signaling Molecule: A Potential Strategy in Osteosarcoma Treatment : Naturally Occuring Molecules and Anticancer Combination Therapies in the Era of Personalized Medicine and Economic CrisisSPINA, Annamaria; SORVILLO, Luca; ESPOSITO, Antonietta et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 30, pp 5394-5403, issn 1381-6128, 10 p.Article

MicroRNA Involvement in Gastrointestinal Stromal Tumor Tumorigenesis : miRNA in the Pathogenesis and Therapy for Gastrointestinal and Hepatic CancersWON KYU KIM; YANG, Han-Kwang; KIM, Hoguen et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 7, pp 1227-1235, issn 1381-6128, 9 p.Article

Microvascular Function/Dysfunction Downstream a Coronary Stenosis : Modifying Cardiovascular Risk Factors: New Markers of Cardiovascular DamageGUARINI, Giacinta; GIUSEPPINA CAPOZZA, Paola; HUQI, Alda et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 13, pp 2366-2374, issn 1381-6128, 9 p.Article

Modulation of Staurosporine-Activated Volume-Sensitive Outwardly Rectifying Cl^- Channel by PI3K/Akt in Cardiomyocytes : Metabolic Syndrome and Cardiovascular Health: A Look Beyond the HorizonYAN LIU; BO WANG; ZHANG, Wei-Wei et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 27, pp 4859-4864, issn 1381-6128, 6 p.Article

Molecular Modeling and Virtual Screening of DNA Methyltransferase Inhibitors : Molecular Modeling and QSAR Studies for Drug DesignMEDINA-FRANCO, José L; YOO, Jakyung.Current pharmaceutical design (Print). 2013, Vol 19, Num 12, pp 2138-2147, issn 1381-6128, 10 p.Article

No-reflow: Incidence and Detection in The Cath-Lab : No Reflow: What's in a Name?NICCOLI, Giampaolo; COSENTINO, Nicola; SPAZIANI, Cristina et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 25, pp 4564-4575, issn 1381-6128, 12 p.Article

Novel Anti-platelet Agents for the Treatment of Stable Angina Pectoris : Stable Angina Pectoris: Novel Therapeutics InsightsBRIASOULIS, Alexandros; TOUSOULIS, Dimitris; BAKOGIANNIS, Constantinos et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 9, pp 1581-1586, issn 1381-6128, 6 p.Article